Analyst Ratings for Boston Scientific (BSX) [Buys]
BSX Rating Summary
BSX Price Target Summary
- Highest: $81.00 (Canaccord Genuity)
- Lowest: $60.00 (Stifel)
- Average: $70.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$70.67 (+2.4%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$70.67 (+2.4%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/1/2024 | Mizuho | Anthony Petrone | Upgrade | Buy (Neutral) |
80.00 (60.00) |
63.26 (68.99) |
9.06% | Details |
| 7/19/2023 | Baird » Updated 4/17/2024 |
David Rescott | New Coverage | Outperform (N/A) |
79.00 (72.00) |
52.61 (68.99) |
31.13% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
